Overview
Chuvash erythrocytosis, characterized by homozygous VHL(R200W) mutation, leads to persistent upregulation of hypoxia-inducible factors (HIF-1 and HIF-2), resulting in chronic erythrocytosis and often iron deficiency, particularly exacerbated by phlebotomy 1.Diagnosis
Elevated hematocrit levels indicative of erythrocytosis
Homozygous VHL(R200W) mutation confirmed via genetic testing
Echocardiographic assessment showing elevated tricuspid regurgitation velocity, indicative of increased pulmonary artery pressure 1
Iron deficiency anemia frequently observed, especially post-phlebotomy 1Management
Regular phlebotomy to manage hematocrit levels and prevent complications 1
Iron supplementation to address iron deficiency anemia, tailored to ferritin levels and clinical need 1
Monitoring of pulmonary artery pressure via echocardiography to assess cardiovascular risk 1Special Populations
Pediatrics: Echocardiographic monitoring essential for early detection of elevated pulmonary artery pressure 1
Iron Deficiency: Special attention to iron supplementation in all age groups, particularly post-phlebotomy 1Key Recommendations
Perform regular echocardiographic assessments to evaluate pulmonary artery pressure in patients with Chuvash erythrocytosis (Evidence: Moderate) 1
Implement phlebotomy as a primary management strategy to control hematocrit levels (Evidence: Moderate) 1
Address iron deficiency with appropriate supplementation, considering ferritin levels and clinical symptoms (Evidence: Moderate) 1References
1 Sable CA, Aliyu ZY, Dham N, Nouraie M, Sachdev V, Sidenko S et al.. Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia). Haematologica 2012. link